Drug Policy

Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.

A new report offers recommendations for extending telehealth treatment of opioid use disorder.

Scholars critique the regulation of psychedelic substances and propose reforms for medical research and use.

Experts consider how regulators can make drugs affordable without hindering research and development.

Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.

A federal task force proposes regulatory solutions to mitigate drug shortages.

Brazil has recently made efforts to streamline the introduction and distribution of drugs.

This Saturday Seminar explores how regulation addresses and affects opioid use and addiction.

The permissive drug approval process enabled by the 21st Century Cures Act may cause public health problems.

The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.

Experts offer solutions to pressing issues in American health care.